SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Snap, Inc. is a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap Inc. is experiencing heavy volatility and high trading volume driven by a combination of a major legal setback regarding youth addiction lawsuits and large-scale, pre-planned insider stock sales by co-founder Bobby Murphy. While some investors are concerned about management credibility and dilution, others are actively debating the company's long-term valuation, potential AR hardware catalysts, and a relief bounce from oversold technical levels.

EyePoint, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.

EyePoint Inc.

EyePoint Pharmaceuticals Inc

EyePoint Pharmaceuticals is seeing significant market activity as investors weigh the potential of its wet AMD program following recent competitive landscape shifts in the TKI sector. The community is actively debating the company's timeline and competitive positioning while monitoring closely for updates on its upcoming pivotal trial results.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending as investors react to the company's confirmed alignment with the FDA to submit an NDA for AXPAXLI by the end of the year, bolstered by data from a single pivotal trial. Community discussions are centered on the significant regulatory de-risking this represents, fueling speculation about potential buyout interest from major pharmaceutical players.

Spdr Dow Jones Industrial Average ETF Trust - Spdr Dow Jones Industrial Average ETF Trust

The Dow Jones Industrial Average ETF is trending as market participants weigh strong corporate earnings and AI infrastructure spending against ongoing geopolitical tensions in the Strait of Hormuz. Investors are actively discussing the sustainability of recent record highs and potential volatility stemming from upcoming labor and inflation data, with community sentiment divided between aggressive bullish momentum and concerns over stretched valuations.

L3Harris Technologies, Inc. engages in the provision of defense and commercial technologies across the air, land, sea, space, and cyber domains. It operates through the following segments: Communication Systems, Integrated Mission Systems, Space and Airborne Systems, and Aerojet Rocketdyne. The Communication Systems segment enables warfighters across all domains with solutions critical to mission success even in the most contested environments. The Integrated Mission Systems segment focuses on the differentiated mission capabilities and prime systems integration for the air, land, and sea domains. The Space and Airborne Systems segment provides full mission solutions as a prime and subsystem integrator in the space, airborne, and cyber domains. The Aerojet Rocketdyne segment includes propulsion, power and armament products and systems to U.S. government, including the DoD, National Aeronautics and Space Administration (“NASA”) and major aerospace and defense prime contractors. The company was founded in 1890 and is headquartered in Melbourne, FL.

L3Harris Technologies Inc

L3Harris Technologies is trending following the major announcement of a proposed partnership with the U.S. Department of War, which includes a $1 billion investment to scale up solid rocket motor production and plans for a standalone IPO of its Missile Solutions unit in late 2026. The community is actively discussing the potential value of this strategic spinoff and its impact on the company's ability to capitalize on the increasing demand for hypersonic and precision-strike missile systems.

Almonty Industries, Inc. engages in the mining, processing, and shipment of tungsten concentrates. Its projects include Almonty Korea Tungsten, Panasquiera mine, Gentung, Almonty Korea Moly, Los Santos mine, and Valtreixal. The company was founded on September 28, 2009 and is headquartered in Dillon, MT.

Almonty Industries Inc

Almonty Industries is trending as investors react to a newly announced $300M share repurchase program, which management initiated to address what they perceive as an undervaluation of the company's high-grade tungsten assets. Community discussion is heavily focused on the stock's role as a critical, non-Chinese supplier for Western defense and semiconductor supply chains, with participants actively debating the potential for an upward trend in EPS as production at the Sangdong mine scales.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is trending as investors digest news of a significant reduction in the company's financial guarantee for a major OpenAI data center project, which some interpret as improved capital discipline while others debate the broader implications for AI-related debt. The community remains heavily divided between bullish sentiment fueled by anticipation of upcoming earnings and institutional data center demand, and bearish concerns regarding the long-term sustainability of AI infrastructure spending.

Quantum Corp. engages in the manufacture of computer storage devices. It provides solutions for storing and protecting information in physical, virtual, and cloud environments. Its products and services include Myriad All-Flash File and Object, StorNext File System Unified Surveillance Platform, ActiveScale Object Storage, DXi Backup Appliances, Scalar Tape Storage, CatDV Media Asset Management, and Cloud-Based Analytics. The company was founded by Joel N. Harrison and James M. McCoy in 1980 and is headquartered in Centennial, CO.

Quantum Corp

Quantum Corp (QMCO) is seeing intense volatility as the community debates whether the stock is a legitimate turnaround play or a classic pump-and-dump scheme driven by algorithmic trading and social media hype. Investors are particularly focused on the upcoming lock-up expiration, leading to heightened speculation around potential dilution and the heavy short interest surrounding the company's data storage business.

Vanguard Index Funds - Vanguard S&P 500 ETF

Vanguard S&P 500 ETF

Market sentiment remains focused on persistent Middle East volatility and Federal Reserve interest rate policy, with investors closely watching potential economic slowdowns while continuing to favor index-based strategies like VOO for long-term compounding. Community discourse is currently split between cautious concerns over an overheated market bubble and a strong, disciplined belief in "VOO and chill" to navigate current economic instability.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology is trending as retail investors weigh record revenue growth and major GPU deployment milestones against persistent concerns over potential share dilution from recent convertible notes. The community remains deeply divided, with bulls pointing to the company's aggressive expansion in AI infrastructure while bears highlight the CEO's communication strategy and past financing activities.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is BioMarin Pharmaceutical (BMRN) Outperforming Other Medical Stocks This Year?

Here is how BioMarin Pharmaceutical (BMRN) and Cardinal Health (CAH) have performed compared to their sector so far this year.

Zacks.com featured highlights include BioMarin Pharmaceutical, Invesco, Centene Corporation, Hewlett Packard Enterprise and Gibraltar Industries 

Five stocks stand out as potentially undervalued by price-to-book measures, including BioMarin Pharmaceutical, Invesco and Centene.

5 Undervalued Price-to-Book Stocks Worth Buying in August

BioMarin, Invesco, Centene, HPE and Gibraltar Industries stand out as undervalued stocks with low price-to-book ratios.

BMRN vs. ILMN: Which Stock Is the Better Value Option?

Wall Street Analysts See a 28.2% Upside in BioMarin (BMRN): Can the Stock Really Move This High?

The mean of analysts' price targets for BioMarin (BMRN) points to a 28.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Why BioMarin Pharmaceutical (BMRN) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

BioMarin to Participate at the Canaccord Genuity 46th Annual Growth Conference on Wednesday, August 12, 2026, at 8:00AM ET in Boston

BioMarin to Participate at the Canaccord Genuity 46th Annual Growth Conference on Wednesday, August 12, 2026, at 8:00AM ET in Boston BioMarin to Participate at the Canaccord Genuity 46th Annual Growth Conference on Wednesday, August 12, 2026, at 8:00AM ET in Boston PR Newswire SAN RAFAEL, Calif...

BMRN Stock Up as Q2 Earnings Beat on Sales Growth, 2026 Outlook Raised

BioMarin stock rises on Q2 sales beat and raises 2026 outlook, highlighting strong Voxzogo growth, Amicus additions and momentum in key therapies.

Compared to Estimates, BioMarin (BMRN) Q2 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for BioMarin (BMRN) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

BioMarin Pharmaceutical (BMRN) Surpasses Q2 Earnings and Revenue Estimates

BioMarin (BMRN) delivered earnings and revenue surprises of +25.00% and +7.31%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

$BMRN Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of $0.23 down -81.60% YoY
• Reported revenue of $989.71M up 19.91% YoY
• BioMarin Pharmaceutical Inc. raised its full-year 2026 total revenue guidance to a range of $3.875 billion to $3.925 billion, with VOXZOGO revenue expected to reach at least $1 billion in 2026.

BioMarin Pharmaceutical, Inc. is a global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. The company has a proven track record of innovation, with nine commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin seeks to unleash the full potential of genetic science by pursuing category-defining medicines that have a profound impact on patients. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997 and is headquartered in San Rafael, CA.

Biomarin Pharmaceutical Inc. - Registered Shares

Amicus Stock Surges To Near 2-Year Highs On BioMarin's $4.8B Buyout Deal

Equity

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info